Offered since 2022, the Emerging Markets ex China Equity strategy invests in high-quality, growing companies with a substantial share of their revenues or assets in emerging markets countries outside of China. The strategy’s benchmark is the MSCI Emerging Markets ex China Index.
We invest in the shares of high-quality, growing businesses at reasonable prices, identified through our disciplined fundamental research process. Our approach is consistent with our Emerging Markets, International, and Global equity strategies, each of which have been investing in Emerging Markets for over 20 years.
Looking for information on ways to invest?
Largest holdings and sector and geographic weights are shown as supplemental information only. The portfolios are actively managed therefore holdings shown may not be current. They should not be considered recommendations to buy or sell any security. It should not be assumed that investment in the securities identified has been or will be profitable. A complete list of holdings for this quarter is available for Emerging Markets ex China Equity here. To request a complete list of holdings for the past year, please contact Harding Loevner.
MSCI Inc. and S&P do not make any express or implied warranties or representations and shall have no liability whatsoever with respect to any GICS data contained herein.
Please click here for Index definitions.
The Emerging Markets ex China Strategy launched on September 14, 2022 and a GIPS composite has not yet been established.